. 2021; 30(2): 110-112

Oncological follow-up with 2-[18F]FDG PET/CT in li fraumeni syndrome

Marylin Acuña Hernandez1, Ivan Fabricio Vega Gonzalez2, Lina Maria Lopez Velez2, Catalina Melo2
1Autonomous University of Bucaramanga (UNAB), Bucaramanga, Santander, Colombia.
2Las Américas Clinic, Medellin, Antioquia, Colombia.

Li-Fraumeni syndrome is a rare disorder caused by abnormalities of the tumor suppressor protein P53 gene. We present the case of a female patient 26 years old with diagnosis of bilateral ductal carcinoma. The genetic panel for BRCA1 and BRCA2 mutations was negative and positive heterozygous germline TP53 gene mutations, considering Li-Fraumeni syndrome. A 2-[18F]FDG PET/CT for post-surgical staging showing right lung hypermetabolic nodule. A lobectomy was accomplished and histopathology reported pulmonary adenocarcinoma. A year later, oncological follow-up was indicated with 2- [18F] FDG PET/CT without evidence of abnormalities.

Keywords: Li-Fraumeni Syndrome, Positron-Emission Tomography, Fluorodeoxyglucose F18, Follow-Up Studies


Marylin Acuña Hernandez, Ivan Fabricio Vega Gonzalez, Lina Maria Lopez Velez, Catalina Melo. Oncological follow-up with 2-[18F]FDG PET/CT in li fraumeni syndrome. . 2021; 30(2): 110-112

Corresponding Author: Marylin Acuña Hernandez, Colombia


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
Google Scholar